Literature DB >> 20851099

Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid.

Panupon Khumsupan1, Ricardo Ramirez, Darin Khumsupan, Vasanthy Narayanaswami.   

Abstract

Curcumin is an antioxidant and anti-inflammatory bioflavonoid that has been recently identified as an anti-amyloid agent as well. To make it more available in its potent form as a potential amyloid disaggregation agent, we employed high-density lipoproteins (HDL), which are lipid-protein complexes that transport plasma cholesterol, to transport curcumin. The objective of this study was to employ reconstituted HDL containing human apoE3 N-terminal (NT) domain, as a vehicle to transport curcumin. The NT domain serves as a ligand to mediate binding and uptake of lipoprotein complexes via the low-density lipoprotein receptor (LDLr) family of proteins located at the cell surface. Reconstituted HDL was prepared with phospholipids and recombinant apoE3-NT domain in the absence or presence of curcumin. Non-denaturing polyacrylamide gel electrophoresis indicated that the molecular mass and Stokes' diameter of HDL bearing curcumin were ~670kDa and ~17nm, respectively, while electron microscopy revealed the presence of discoidal particles. Fluorescence emission spectra of HDL bearing (the intrinsically fluorescent) curcumin indicated that the wavelength of maximal fluorescence emission (λ(max)) of curcumin was ~495nm, which is highly blue-shifted compared to λ(max) of curcumin in solvents of varying polarity (λ(max) ranging from 515-575nm) or in aqueous buffers. In addition, an enormous enhancement in fluorescence emission intensity was noted in curcumin-containing HDL compared to curcumin in aqueous buffers. Curcumin fluorescence emission was quenched to a significant extent by lipid-based quenchers but not by aqueous quenchers. These observations indicate that curcumin has partitioned efficiently into the hydrophobic milieu of the phospholipid bilayer of HDL. Functional assays indicated that the LDLr-binding ability of curcumin-containing HDL with apoE3-NT is similar to that of HDL without curcumin. Taken together, we report that apoE-containing HDL has a tremendous potential as a 'nanovehicle' with a homing device to transport curcumin to target sites.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851099      PMCID: PMC2997894          DOI: 10.1016/j.bbamem.2010.09.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  57 in total

Review 1.  The nanodisc: a novel tool for membrane protein studies.

Authors:  Jonas Borch; Thomas Hamann
Journal:  Biol Chem       Date:  2009-08       Impact factor: 3.915

2.  Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain.

Authors:  F Bao; H Arai; S Matsushita; S Higuchi; H Sasaki
Journal:  Neuroreport       Date:  1996-07-29       Impact factor: 1.837

3.  The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E.

Authors:  C A Fisher; V Narayanaswami; R O Ryan
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

Authors:  C Ireson; S Orr; D J Jones; R Verschoyle; C K Lim; J L Luo; L Howells; S Plummer; R Jukes; M Williams; W P Steward; A Gescher
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

5.  Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.

Authors:  C D Mamotte; M Sturm; J I Foo; F M van Bockxmeer; R R Taylor
Journal:  Am J Physiol       Date:  1999-03

6.  Complex of human apolipoprotein C-1 with phospholipid: thermodynamic or kinetic stability?

Authors:  Olga Gursky; Donald L Gantz
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

7.  Putting cholesterol in its place: apoE and reverse cholesterol transport.

Authors:  Robert W Mahley; Yadong Huang; Karl H Weisgraber
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

Authors:  M Garcia-Alloza; L A Borrelli; A Rozkalne; B T Hyman; B J Bacskai
Journal:  J Neurochem       Date:  2007-04-30       Impact factor: 5.372

9.  A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier.

Authors:  B Dehouck; L Fenart; M P Dehouck; A Pierce; G Torpier; R Cecchelli
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

10.  Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion.

Authors:  M T Huang; W Ma; Y P Lu; R L Chang; C Fisher; P S Manchand; H L Newmark; A H Conney
Journal:  Carcinogenesis       Date:  1995-10       Impact factor: 4.944

View more
  8 in total

1.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

Review 2.  Learning from biology: synthetic lipoproteins for drug delivery.

Authors:  Huang Huang; William Cruz; Juan Chen; Gang Zheng
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-24

3.  ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.

Authors:  Xiuli Mu; Xi Wang; Yan Wei; Chaochao Wen; Qi Zhang; Chunyang Xu; Chang Liu; Chan Zhang; Fanxiu Meng; Na Zhao; Tao Gong; Rui Guo; Gongqin Sun; Gaopeng Li; Hongwei Zhang; Qin Qin; Jun Xu; Xiushan Dong; Lumei Wang; Baofeng Yu
Journal:  Cancer Gene Ther       Date:  2019-10-23       Impact factor: 5.987

4.  Apoptosis induction and anti-cancer activity of LeciPlex formulations.

Authors:  Vivek V Dhawan; Ganesh V Joshi; Ankitkumar S Jain; Yuvraj P Nikam; Rajiv P Gude; Rita Mulherkar; Mangal S Nagarsenker
Journal:  Cell Oncol (Dordr)       Date:  2014-09-10       Impact factor: 6.730

5.  Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship.

Authors:  Mark T Lek; Siobanth Cruz; Nnejiuwa U Ibe; Wendy H J Beck; John K Bielicki; Paul M M Weers; Vasanthy Narayanaswami
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

6.  Targeted intracellular delivery of resveratrol to glioblastoma cells using apolipoprotein E-containing reconstituted HDL as a nanovehicle.

Authors:  Sea H Kim; Birendra Babu Adhikari; Siobanth Cruz; Michael P Schramm; Joe A Vinson; Vasanthy Narayanaswami
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

Review 7.  Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.

Authors:  Skylar T Chuang; Siobanth Cruz; Vasanthy Narayanaswami
Journal:  Nanomaterials (Basel)       Date:  2020-05-08       Impact factor: 5.076

Review 8.  Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.

Authors:  Xueqin Zhang; Gangliang Huang
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.